Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherapeutic, Molecular, and Immune Approaches Aimed at Preventing Relapse-Reference-Cited by-同舟云学术

Allogeneic Transplantation for Pediatric Acute Lymphoblastic Leukemia: The Emerging Role of Peritransplantation Minimal Residual Disease/Chimerism Monitoring and Novel Chemotherapeutic, Molecular, and Immune Approaches Aimed at Preventing Relapse

Published:2009-01 Issue:1 Volume:15 Page:62-71
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pulsipher Michael A.,Bader Peter,Klingebiel Thomas,Cooper Laurence J.N.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference101 articles.

1. Children's Cancer Group trials in childhood acute lymphoblastic leukemia, 1983-1995;Gaynon;Leukemia,2000

2. Acute lymphoblastic leukemia;Pui;N Engl J Med,1998

3. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM Study Group from 1981 to 1995;Schrappe;Leukemia,2000

4. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review;Hahn;Biol Blood Marrow Transplant,2005

5. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multicolour and lineage-specific interphase chromosome Flow-FISH: method development and clinical validation;Pathology;2024-08

2. Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia;Transplantation and Cellular Therapy;2024-02

3. Highly-sensitive chimerism analysis in blood after allogeneic hematopoietic cell transplantation in childhood leukemia: Results from the Nordic Microchimerism Study;Frontiers in Hematology;2023-02-06

4. Next-Generation Sequencing for Measurable Residual Disease Assessment in Acute Leukemia;Advances in Molecular Pathology;2021-11

5. How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment;Clinical Lymphoma Myeloma and Leukemia;2020-09